NYSE:UE
NYSE:UERetail REITs

The Bull Case For Urban Edge Properties (UE) Could Change Following Q3 Earnings Beat and Dividend Announcement

Urban Edge Properties recently declared a regular quarterly dividend of US$0.19 per common share, payable on December 31, 2025, to shareholders of record as of December 15, 2025. The company also reported third-quarter 2025 earnings that surpassed analyst expectations and raised its full-year net income guidance, highlighting improved operational performance. We'll explore how the upward revision in earnings guidance influences Urban Edge Properties' investment narrative and future...
NYSE:UP
NYSE:UPAirlines

Wheels Up Experience (UP): Assessing Valuation After Q3 Losses and Transformation Initiatives

Wheels Up Experience (NYSE:UP) just released its third quarter earnings, highlighting ongoing losses and a drop in revenue. Alongside the results, the company rolled out fresh initiatives and updates, showing a continued focus on long-term transformation. See our latest analysis for Wheels Up Experience. Despite a string of transformation updates, including a new Signature Membership program and continued backing from major investors, Wheels Up Experience’s 1-year total shareholder return...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

What Recent Supply Chain Wins Could Mean for Power Solutions International’s Share Price in 2025

If you have ever wondered whether Power Solutions International could be one of the market’s best kept secrets or simply overpriced, you are not alone. Let’s dive in together and find out what’s really driving its value. Despite powering ahead with 134.6% gains over the past year (and an eye-popping 3653.7% rise over three years), the stock has pulled back sharply, dropping 23.3% in just the last week. Recent headlines have brought attention to supply chain improvements and new large-scale...
NYSE:IVT
NYSE:IVTRetail REITs

InvenTrust Properties (IVT): Exploring Valuation After Strong Q3 Results and Lowered Full-Year Outlook

InvenTrust Properties (IVT) released its third quarter results on Tuesday, reporting higher revenue and a jump in net income compared to last year. At the same time, the company trimmed its full-year earnings guidance, which caught investor attention. See our latest analysis for InvenTrust Properties. After a strong run of revenue and income growth, InvenTrust Properties’ share price has held steady, closing at $27.50. Still, the market’s caution is clear, with the year-to-date share price...
NasdaqCM:SGMO
NasdaqCM:SGMOBiotechs

Sangamo Therapeutics (SGMO) Is Down 21.1% After Nasdaq Compliance Extension and Q3 Revenue Decline - Has The Bull Case Changed?

Sangamo Therapeutics recently reported its third-quarter 2025 results, revealing a sharp year-over-year revenue decline to US$581,000 and a net loss of US$34.93 million. Alongside operational losses, the company was granted a 180-day Nasdaq extension to regain compliance with minimum bid price rules, highlighting concerns around ongoing listing status. We will assess how these financial pressures and Nasdaq compliance challenges weigh on Sangamo's investment outlook and pipeline...
NasdaqGS:RIGL
NasdaqGS:RIGLBiotechs

Rigel Pharmaceuticals (RIGL): Valuation Insights After Raised 2025 Guidance and Q3 Performance

Rigel Pharmaceuticals (RIGL) raised its 2025 revenue guidance to $285 million to $290 million after reporting strong third-quarter earnings and record net product sales. Investors are taking notice as the company signals confidence in its outlook. See our latest analysis for Rigel Pharmaceuticals. After lifting its guidance and reporting robust Q3 results, Rigel’s stock has shown powerful momentum, with a 22.4% one-month share price return and an impressive 103% share price surge...
NYSE:JBTM
NYSE:JBTMMachinery

How Should Investors View JBT Marel After Shares Surge 12% This Week?

Curious if JBT Marel is a hidden gem or just fairly priced? Let’s dig into what really drives its value. In the past week, JBT Marel shares surged 12.1%, and they’re up 19.2% over the last year, showing some real momentum after a bumpy 30-day patch. Industry watchers have been buzzing about JBT Marel in recent months as the company continues to expand into automated food technology and makes bold strategic acquisitions. These moves have caught the market’s attention, fueling optimism about...
NYSE:CYD
NYSE:CYDMachinery

Assessing China Yuchai International (NYSE:CYD) Valuation Following Increased Stake in HL Global Enterprises

China Yuchai International (NYSE:CYD) recently raised its stake in HL Global Enterprises to 49.11%. By expanding its influence over HLGE's operations, the company signals a clear intent to deepen its involvement in the hospitality sector. See our latest analysis for China Yuchai International. China Yuchai's latest move to boost its stake in HL Global Enterprises arrives as shares continue a remarkable surge, highlighted by a 295.54% year-to-date share price return and a three-year total...
NasdaqGS:PPC
NasdaqGS:PPCFood

How Pilgrim's Pride's Nine-Month Earnings Growth Could Shape the PPC Investment Outlook

Pilgrim's Pride Corporation announced its third quarter and nine-month earnings results, reporting quarterly sales of US$4,759.34 million and nine-month sales of US$13.98 billion, with net income for the nine-month period reaching US$994.37 million. While third quarter net income slightly decreased year over year, the company delivered higher sales and profits for the nine months, reflecting ongoing strength in its operations and demand for its products. Following these results, we'll assess...
NasdaqGS:CNOB
NasdaqGS:CNOBBanks

Should Piper Sandler's Upgrade After the FLIC Merger Drive a Rethink for ConnectOne (CNOB) Investors?

Piper Sandler recently upgraded ConnectOne Bancorp, assigning an "Overweight" rating and citing confidence in the company's growth potential and earnings outlook. This analyst endorsement follows ConnectOne Bancorp's completed integration of The First of Long Island Corporation and highlights renewed investor focus on its merger-driven expansion and operational performance. We’ll examine how Piper Sandler’s upgraded rating, which highlights growth potential, could shift the investment...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

GoodRx (GDRX): A Fresh Look at Valuation After Recent Share Price Decline

GoodRx Holdings (GDRX) has seen its stock under pressure lately, with a 29% drop over the past month. Investors are considering the company’s performance as they assess how recent trends in the healthcare discount space could impact future results. See our latest analysis for GoodRx Holdings. After a rocky few months, GoodRx Holdings’ downward momentum is hard to ignore. Despite brief rallies, the share price return year-to-date is down nearly 32%, and the one-year total shareholder return...
NasdaqGM:CCLD
NasdaqGM:CCLDHealthcare Services

CareCloud (CCLD): Evaluating Valuation After Recent 17% Share Price Jump

CareCloud (CCLD) shares have shown steady movement lately, with investors weighing recent performance trends. Over the past week, returns saw a sharp increase of 17%. In addition, the past 3 months delivered solid gains overall. See our latest analysis for CareCloud. Zooming out, CareCloud has seen momentum shift in recent months, with a 17% share price return over the past week helping to recover ground lost earlier in the year. Even so, the stock’s one-year total shareholder return sits at...
NYSE:INFA
NYSE:INFASoftware

Informatica (INFA): Assessing Valuation as Fundamentals and Market Sentiment Shift

Informatica (INFA) has been drawing some attention lately, as investors weigh its recent performance and underlying fundamentals. With a year-to-date return slightly negative and modest revenue growth, there is fresh debate about how the stock stacks up in the software sector. See our latest analysis for Informatica. Looking at the bigger picture, Informatica’s share price has drifted lower in recent months, reflecting a cautious mood after a period of modest gains. Despite this, its...
NasdaqGS:OMDA
NasdaqGS:OMDAHealthcare

Omada Health (OMDA): Is the Stock Overvalued After Recent Volatility?

Omada Health (OMDA) has been the subject of some investor attention lately. It is worth taking a closer look at how the company's stock has performed in the past month and what might be driving sentiment. See our latest analysis for Omada Health. Omada Health’s share price return has been volatile lately, dropping 17.3% over the last week alone and down 15.3% for the month, even as it remains up for the past quarter. Momentum appears to have faded in the short term, hinting at shifting...
NasdaqGS:COHU
NasdaqGS:COHUSemiconductor

Did Narrowing Losses and Conservative Guidance Just Shift Cohu’s (COHU) Investment Narrative?

Cohu, Inc. recently released its third quarter 2025 results, reporting US$126.25 million in sales and a net loss of US$4.1 million, alongside sales guidance of US$122 million +/- US$7 million for the fourth quarter. While losses narrowed year-over-year, nine-month net losses increased despite higher sales, and no additional shares were repurchased in the latest buyback tranche. We will examine how the company's narrowing quarterly loss and conservative fourth-quarter outlook could influence...
NYSE:ALSN
NYSE:ALSNMachinery

Did Allison Transmission's (ALSN) Weaker Guidance and Defense Expansion Just Shift Its Investment Narrative?

Allison Transmission Holdings recently released its third-quarter results, reporting sales of US$693 million and net income of US$137 million, both down from a year earlier, and updated its 2025 full-year guidance with expected net sales between US$2.98 billion and US$3.03 billion and net income of US$620 million to US$650 million. Alongside its earnings announcement, the company expanded its global defense network, naming a new authorized channel partner in Poland to strengthen support for...
NYSE:OPTU
NYSE:OPTUMedia

Optimum Communications (ATUS): Examining Valuation as Share Price Stabilizes After Steep Declines

Optimum Communications (NYSE:ATUS) shares saw subtle movement this week, offering investors fresh perspective on the company’s current valuation. With performance figures in hand, a closer inspection can reveal trends that may impact future expectations. See our latest analysis for Optimum Communications. After a period of sharp declines, Optimum Communications’ share price has shown only modest swings lately, even as the company navigates a shifting media landscape and ongoing operational...
NasdaqCM:NAGE
NasdaqCM:NAGELife Sciences

Niagen Bioscience (NAGE) Is Up After Record Q3 and Share Buyback Plan – What's Changed

Niagen Bioscience recently reported record third-quarter 2025 results, featuring a 33% year-over-year sales growth to US$33.99 million and implemented a US$10 million share repurchase program authorized through October 2027. The company reinforced its operational momentum by reaffirming upgraded full-year sales guidance and expanding distribution for its proprietary NAD+ products, signifying continued commitment to product innovation and healthcare partnerships. We’ll explore how the robust...
NYSE:CVI
NYSE:CVIOil and Gas

What CVR Energy (CVI)'s Swing to Profit and New Shelf Offering Means For Shareholders

CVR Energy, Inc. recently filed a universal shelf registration statement, enabling it to offer a wide range of securities, following its report of third-quarter results with net income of US$374 million compared to a net loss a year earlier and increased refining throughput and production. This marked turnaround in quarterly earnings, alongside higher operating output, highlights improved operational performance and potential strengthening of the company’s financial position. Let's explore...
NYSE:CTEV
NYSE:CTEVHealthcare Services

Claritev (CTEV): Assessing Valuation Following Upbeat Earnings and Raised Revenue Guidance

Claritev (NYSE:CTEV) is in focus after announcing improved third-quarter results and raising full-year revenue guidance. The company reported stronger sales and sharply reduced losses, which signals momentum building into the second half of 2025. See our latest analysis for Claritev. The rally in Claritev’s stock has been hard to ignore; the share price closed at $69.25 after a one-day gain of 11.77%. The company now boasts a staggering year-to-date price return of 434.75%. These moves follow...
NYSE:BW
NYSE:BWElectrical

Babcock & Wilcox Enterprises (BW) Is Up 55.4% After Securing US$1.5 Billion AI Data Center Power Deal – Has The Bull Case Changed?

Babcock & Wilcox Enterprises recently announced a series of major developments, including a more than US$1.5 billion agreement with Applied Digital to design and install gigawatt-scale natural gas power plants tailored for AI Data Center infrastructure, along with the planned redemption of all outstanding 8.125% Senior Notes due 2026. These initiatives point to an acceleration of Babcock & Wilcox's expansion into advanced energy markets, emphasizing its role in powering emerging high-demand...